Hemostatic Management During Oral Surgery in Patients With a Left-Ventricular Assist System Undergoing High-Level Anticoagulant Therapy: Efficacy of Low Molecular Weight Heparin

Journal of Oral and Maxillofacial Surgery

Volumn 66, Issue 3, 2008, Pages 568-571

  Morimoto, Yoshinari ^a   Niwa, Hitoshi ^a   Hanatani, Akihisa ^b   Nakatani, Takeshi ^b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; WARFARIN;

ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; ODONTOGENIC CYST; ORAL SURGERY; PERIODONTITIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; TOOTH EXTRACTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICOAGULANTS; ASSISTED CIRCULATION; CARDIOMYOPATHY, DILATED; FEMALE; HEMOSTASIS, SURGICAL; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MAXILLARY DISEASES; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RADICULAR CYST; TOOTH EXTRACTION;

EID: 38949189677     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2007.06.637     Document Type: Article

References (12)

1. Lund J.P., Drews T., Hetzer R., et al. Oral surgical management of patients with mechanical circulatory support. Int J Oral Maxillofac Surg 31 (2003) 629
2. Little J.W., Falace D.A., and Miller C.S. Bleeding disorder. Dental Management of the Medically Compromised Patient. (ed 6) (2002), Mosby, St Louis, MO 332
3. Dunn C.J., and Jarvis B. Dalteparin: An update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease. Drugs 60 (2000) 203
4. Little J.W., Miller C.S., Henry R.G., et al. Antithrombotic agents: Implications in dentistry. Oral Surg Oral Med Oral Pathol 93 (2002) 544
5. Ota K., Suzuki T., Koshikawa S., et al. Clinical evaluation of low molecular weight heparin, FR-860, in hemodialysis patients with lesions and high risk of hemorrhage: A multicenter cooperative study in comparison with heparin. Med Consult New Remedies 27 (1990) 33 (in Japanese)
6. Todd D.W., and Roman A. Outpatient use of low molecular weight heparin in an anticoagulated patient requiring oral surgery: Case report. J Oral Maxillofac Surg 59 (2001) 1090
7. Leong C.J., and Rada R.E. The use of low molecular weight heparins in outpatient oral surgery for patients receiving anticoagulant therapy. J Am Dent Assoc 133 (2002) 1083
8. Bloomer C.R. Excessive hemorrhage after dental extraction using low molecular weight heparin (Lovenox) anticoagulant therapy. J Oral Maxillofac Surg 62 (2004) 101
9. Kovacs M.J., Kearon C., Rodger M., et al. Single-arm study of bridging therapy with low molecular weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 110 (2004) 1658
10. Douketis J.D., Johnson J.A., and Turpie A.G. Low molecular weight heparin as bridging anticoagulation during interruption of warfarin: Assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 164 (2004) 1319
11. Hull R.D., Pineo G.F., Francis C., et al. Low molecular weight heparin prophylaxis using dalteparin in close proximity to surgery versus warfarin in hip arthroplasty patients. Arch Intern Med 160 (2000) 2199
12. Tinmouth A.H., Morrow B.H., Cruickshank M., et al. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 35 (2001) 669